Abdominal 0 9 0 9 B-chronic_disease
fistula 10 17 10 17 I-chronic_disease

Absolute 0 8 18 26 B-clinical_variable
neutrophil 9 19 27 37 I-clinical_variable
count 20 25 38 43 I-clinical_variable
> 26 27 44 45 O
= 27 28 45 46 O
1,200 29 34 47 52 B-lower_bound
/ 34 35 52 53 I-lower_bound
mcL 35 38 53 56 I-lower_bound

Active 0 6 57 63 B-chronic_disease
peptic 7 13 64 70 I-chronic_disease
ulcer 14 19 71 76 I-chronic_disease
disease 20 27 77 84 I-chronic_disease

Adenocarcinoma 0 14 85 99 B-cancer
of 15 17 100 102 I-cancer
the 18 21 103 106 I-cancer
bladder 22 29 107 114 I-cancer

Any 0 3 115 118 O
history 4 11 119 126 O
of 12 14 127 129 O
congenital 15 25 130 140 B-chronic_disease
long 26 30 141 145 I-chronic_disease
QT 31 33 146 148 I-chronic_disease
syndrome 34 42 149 157 I-chronic_disease

Any 0 3 158 161 O
of 4 6 162 164 O
the 7 10 165 168 O
following 11 20 169 178 O
that 21 25 179 183 O
have 26 30 184 188 O
not 31 34 189 192 O
resolved 35 43 193 201 O
within 44 50 202 208 O
28 51 53 209 211 B-upper_bound
days 54 58 212 216 I-upper_bound
before 59 65 217 223 I-upper_bound
the 66 69 224 227 O
first 70 75 228 233 O
dose 76 80 234 238 O
of 81 83 239 241 O
study 84 89 242 247 O
treatment 90 99 248 257 B-treatment

Any 0 3 258 261 O
other 4 9 262 267 O
signs 10 15 268 273 O
indicative 16 26 274 284 O
of 27 29 285 287 O
pulmonary 30 39 288 297 B-chronic_disease
hemorrhage 40 50 298 308 I-chronic_disease
within 51 57 309 315 O
3 58 59 316 317 B-upper_bound
months 60 66 318 324 I-upper_bound
before 67 73 325 331 O
the 74 77 332 335 O
first 78 83 336 341 O
dose 84 88 342 346 O
of 89 91 347 349 O
study 92 97 350 355 O
treatment 98 107 356 365 B-treatment

Aspartate 0 9 366 375 B-clinical_variable
aminotransferase 10 26 376 392 I-clinical_variable
( 27 28 393 394 I-clinical_variable
AST 28 31 394 397 I-clinical_variable
) 31 32 397 398 I-clinical_variable
( 33 34 399 400 O
serum 34 39 400 405 B-clinical_variable
glutamic 40 48 406 414 I-clinical_variable
oxaloacetic 49 60 415 426 I-clinical_variable
transaminase 61 73 427 439 I-clinical_variable
[ 74 75 440 441 I-clinical_variable
SGOT])/alanine 75 89 441 455 I-clinical_variable
aminotransferase 90 106 456 472 I-clinical_variable
( 107 108 473 474 I-clinical_variable
ALT 108 111 474 477 I-clinical_variable
) 111 112 477 478 I-clinical_variable
( 113 114 479 480 O
serum 114 119 480 485 B-clinical_variable
glutamate 120 129 486 495 I-clinical_variable
pyruvate 130 138 496 504 I-clinical_variable
transaminase 139 151 505 517 I-clinical_variable
[ 152 153 518 519 I-clinical_variable
SGPT 153 157 519 523 I-clinical_variable
] 157 158 523 524 I-clinical_variable
) 158 159 524 525 O
= 160 161 526 527 O
< 161 162 527 528 O
3.0 163 166 529 532 B-upper_bound
x 167 168 533 534 I-upper_bound
institutional 169 182 535 548 I-upper_bound
upper 183 188 549 554 I-upper_bound
limit 189 194 555 560 I-upper_bound
of 195 197 561 563 I-upper_bound
normal 198 204 564 570 I-upper_bound
( 205 206 571 572 I-upper_bound
ULN 206 209 572 575 I-upper_bound
) 209 210 575 576 I-upper_bound

Bowel 0 5 577 582 B-chronic_disease
obstruction 6 17 583 594 I-chronic_disease
or 18 20 595 597 O
gastric 21 28 598 605 B-chronic_disease
outlet 29 35 606 612 I-chronic_disease
obstruction 36 47 613 624 I-chronic_disease

Cardiomyopathy 0 14 625 639 B-chronic_disease

Cardiovascular 0 14 640 654 B-chronic_disease
disorders 15 24 655 664 I-chronic_disease

Clear 0 5 665 670 B-cancer
cell 6 10 671 675 I-cancer
renal 11 16 676 681 B-cancer
cell 17 21 682 686 I-cancer
carcinoma 22 31 687 696 B-cancer

Clinically 0 10 697 707 O
- 10 11 707 708 O
significant 11 22 708 719 O
cardiac 23 30 720 727 B-chronic_disease
arrhythmias 31 42 728 739 I-chronic_disease

Clinically 0 10 740 750 O
- 10 11 750 751 O
significant 11 22 751 762 O
gastrointestinal 23 39 763 779 B-chronic_disease
bleeding 40 48 780 788 I-chronic_disease
within 49 55 789 795 O
6 56 57 796 797 B-upper_bound
months 58 64 798 804 I-upper_bound
before 65 71 805 811 I-upper_bound
the 72 75 812 815 O
first 76 81 816 821 O
dose 82 86 822 826 O
of 87 89 827 829 O
study 90 95 830 835 B-treatment
treatment 96 105 836 845 I-treatment

Concurrent 0 10 846 856 O
uncontrolled 11 23 857 869 B-chronic_disease
hypertension 24 36 870 882 I-chronic_disease
defined 37 44 883 890 O
as 45 47 891 893 O
sustained 48 57 894 903 B-clinical_variable
blood 58 63 904 909 I-clinical_variable
pressure 64 72 910 918 I-clinical_variable
( 73 74 919 920 I-clinical_variable
BP 74 76 920 922 I-clinical_variable
) 76 77 922 923 I-clinical_variable
> 78 79 924 925 O
140 80 83 926 929 B-lower_bound
mmHg 84 88 930 934 I-lower_bound
systolic 89 97 935 943 B-clinical_variable
, 97 98 943 944 O
or 99 101 945 947 O
> 102 103 948 949 O
90 104 106 950 952 B-lower_bound
mmHg 107 111 953 957 I-lower_bound
diastolic 112 121 958 967 B-clinical_variable
despite 122 129 968 975 O
optimal 130 137 976 983 B-treatment
antihypertensive 138 154 984 1000 I-treatment
treatment 155 164 1001 1010 I-treatment
within 165 171 1011 1017 O
7 172 173 1018 1019 B-upper_bound
days 174 178 1020 1024 I-upper_bound
of 179 181 1025 1027 O
the 182 185 1028 1031 O
first 186 191 1032 1037 O
dose 192 196 1038 1042 O
of 197 199 1043 1045 O
study 200 205 1046 1051 O
treatment 206 215 1052 1061 O

Congestive 0 10 1062 1072 B-chronic_disease
heart 11 16 1073 1078 I-chronic_disease
failure 17 24 1079 1086 I-chronic_disease
( 25 26 1087 1088 I-chronic_disease
CHF 26 29 1088 1091 I-chronic_disease
): 29 31 1091 1093 I-chronic_disease
New 32 35 1094 1097 B-clinical_variable
York 36 40 1098 1102 I-clinical_variable
Heart 41 46 1103 1108 I-clinical_variable
Association 47 58 1109 1120 I-clinical_variable
( 59 60 1121 1122 I-clinical_variable
NYHA 60 64 1122 1126 I-clinical_variable
) 64 65 1126 1127 I-clinical_variable
class 66 71 1128 1133 B-lower_bound
III 72 75 1134 1137 I-lower_bound
( 76 77 1138 1139 O
moderate 77 85 1139 1147 O
) 85 86 1147 1148 O
or 87 89 1149 1151 O
class 90 95 1152 1157 B-upper_bound
IV 96 98 1158 1160 I-upper_bound
( 99 100 1161 1162 O
severe 100 106 1162 1168 O
) 106 107 1168 1169 O
at 108 110 1170 1172 O
the 111 114 1173 1176 O
time 115 119 1177 1181 O
of 120 122 1182 1184 O
screening 123 132 1185 1194 O

Creatinine 0 10 1195 1205 B-clinical_variable
= 11 12 1206 1207 O
< 12 13 1207 1208 O
1.5 14 17 1209 1212 B-upper_bound
x 18 19 1213 1214 I-upper_bound
ULN 20 23 1215 1218 I-upper_bound
OR 24 26 1219 1221 O
creatinine 27 37 1222 1232 B-clinical_variable
clearance 38 47 1233 1242 I-clinical_variable
> 48 49 1243 1244 O
= 49 50 1244 1245 O
40 51 53 1246 1248 B-lower_bound
mL 54 56 1249 1251 I-lower_bound
/ 56 57 1251 1252 I-lower_bound
min/1.73 57 65 1252 1260 I-lower_bound
m^2 66 69 1261 1264 I-lower_bound
( 70 71 1265 1266 O
calculated 71 81 1266 1276 O
using 82 87 1277 1282 O
the 88 91 1283 1286 O
Chronic 92 99 1287 1294 B-clinical_variable
Kidney 100 106 1295 1301 I-clinical_variable
Disease 107 114 1302 1309 I-clinical_variable
- 114 115 1309 1310 I-clinical_variable
Epidemiology 115 127 1310 1322 I-clinical_variable
Collaboration 128 141 1323 1336 I-clinical_variable
[ 142 143 1337 1338 I-clinical_variable
CKD 143 146 1338 1341 I-clinical_variable
- 146 147 1341 1342 I-clinical_variable
EPI 147 150 1342 1345 I-clinical_variable
] 150 151 1345 1346 I-clinical_variable
equation 152 160 1347 1355 O
or 161 163 1356 1358 O
Cockcroft 164 173 1359 1368 O
- 173 174 1368 1369 O
Gault 174 179 1369 1374 O
formula 180 187 1375 1382 O
) 187 188 1382 1383 O
for 189 192 1384 1387 O
patients 193 201 1388 1396 O
with 202 206 1397 1401 O
creatinine 207 217 1402 1412 B-clinical_variable
levels 218 224 1413 1419 I-clinical_variable
above 225 230 1420 1425 O
institutional 231 244 1426 1439 O
normal 245 251 1440 1446 O

Diverticulitis 0 14 1447 1461 B-chronic_disease
, 14 15 1461 1462 O
cholecystitis 16 29 1463 1476 B-chronic_disease
, 29 30 1476 1477 O
symptomatic 31 42 1478 1489 O
cholangitis 43 54 1490 1501 B-chronic_disease
or 55 57 1502 1504 O
appendicitis 58 70 1505 1517 B-chronic_disease

For 0 3 1518 1521 O
disease 4 11 1522 1529 O
specific 12 20 1530 1538 O
studies 21 28 1539 1546 O
: 28 29 1546 1547 O
the 30 33 1548 1551 O
subject 34 41 1552 1559 O
has 42 45 1560 1563 O
had 46 49 1564 1567 O
evidence 50 58 1568 1576 O
within 59 65 1577 1583 O
2 66 67 1584 1585 B-upper_bound
years 68 73 1586 1591 I-upper_bound
of 74 76 1592 1594 O
the 77 80 1595 1598 O
start 81 86 1599 1604 O
of 87 89 1605 1607 O
study 90 95 1608 1613 B-treatment
treatment 96 105 1614 1623 I-treatment
of 106 108 1624 1626 O
another 109 116 1627 1634 O
malignancy 117 127 1635 1645 B-cancer
which 128 133 1646 1651 O
required 134 142 1652 1660 O
systemic 143 151 1661 1669 B-treatment
treatment 152 161 1670 1679 I-treatment

Gastrointestinal 0 16 1680 1696 B-chronic_disease
disorders 17 26 1697 1706 I-chronic_disease
particularly 27 39 1707 1719 O
those 40 45 1720 1725 O
associated 46 56 1726 1736 O
with 57 61 1737 1741 O
a 62 63 1742 1743 O
high 64 68 1744 1748 O
risk 69 73 1749 1753 O
of 74 76 1754 1756 O
perforation 77 88 1757 1768 O
or 89 91 1769 1771 O
fistula 92 99 1772 1779 O
formation 100 109 1780 1789 O

Gastrointestinal 0 16 1790 1806 B-chronic_disease
perforation 17 28 1807 1818 I-chronic_disease

Hemoglobin 0 10 1819 1829 B-clinical_variable
> 11 12 1830 1831 O
= 12 13 1831 1832 O
9 14 15 1833 1834 B-lower_bound
g 16 17 1835 1836 I-lower_bound
/ 17 18 1836 1837 I-lower_bound
dL 18 20 1837 1839 I-lower_bound

Hemoptysis 0 10 1840 1850 B-clinical_variable
of 11 13 1851 1853 O
> 14 15 1854 1855 O
= 15 16 1855 1856 O
0.5 17 20 1857 1860 B-lower_bound
teaspoon 21 29 1861 1869 I-lower_bound
( 30 31 1870 1871 I-lower_bound
2.5 31 34 1871 1874 I-lower_bound
mL 35 37 1875 1877 I-lower_bound
) 37 38 1877 1878 I-lower_bound
of 39 41 1879 1881 I-lower_bound
red 42 45 1882 1885 I-lower_bound
blood 46 51 1886 1891 I-lower_bound
within 52 58 1892 1898 O
3 59 60 1899 1900 B-upper_bound
months 61 67 1901 1907 I-upper_bound
before 68 74 1908 1914 I-upper_bound
the 75 78 1915 1918 O
first 79 84 1919 1924 O
dose 85 89 1925 1929 O
of 90 92 1930 1932 O
study 93 98 1933 1938 O
treatment 99 108 1939 1948 B-treatment

Histologically 0 14 1949 1963 O
confirmed 15 24 1964 1973 O
diagnosis 25 34 1974 1983 O
of 35 37 1984 1986 O
metastatic 38 48 1987 1997 B-cancer

Histologically 0 14 1998 2012 O
confirmed 15 24 2013 2022 O
diagnosis 25 34 2023 2032 O
of 35 37 2033 2035 O
metastatic 38 48 2036 2046 B-cancer
, 48 49 2046 2047 O
genitourinary 50 63 2048 2061 B-cancer
solid 64 69 2062 2067 I-cancer
tumor 70 75 2068 2073 I-cancer

History 0 7 2074 2081 O
of 8 10 2082 2084 O
major 11 16 2085 2090 B-treatment
surgery 17 24 2091 2098 I-treatment

History 0 7 2099 2106 O
of 8 10 2107 2109 O
organ 11 16 2110 2115 B-treatment
transplant 17 27 2116 2126 I-treatment

History 0 7 2127 2134 O
of 8 10 2135 2137 O
severe 11 17 2138 2144 O
hypersensitivity 18 34 2145 2161 O
reaction 35 43 2162 2170 O
to 44 46 2171 2173 O
any 47 50 2174 2177 O
monoclonal 51 61 2178 2188 B-allergy_name
antibody 62 70 2189 2197 I-allergy_name

In 0 2 2198 2200 O
addition 3 11 2201 2209 O
, 11 12 2209 2210 O
complete 13 21 2211 2219 O
wound 22 27 2220 2225 O
healing 28 35 2226 2233 O
from 36 40 2234 2238 O
prior 41 46 2239 2244 B-treatment
surgery 47 54 2245 2252 I-treatment
must 55 59 2253 2257 O
be 60 62 2258 2260 O
confirmed 63 72 2261 2270 O
at 73 75 2271 2273 O
least 76 81 2274 2279 O
28 82 84 2280 2282 B-lower_bound
days 85 89 2283 2287 I-lower_bound
before 90 96 2288 2294 I-lower_bound
the 97 100 2295 2298 O
first 101 106 2299 2304 O
dose 107 111 2305 2309 O
of 112 114 2310 2312 O
cabozantinib 115 127 2313 2325 B-treatment
irrespective 128 140 2326 2338 O
of 141 143 2339 2341 O
the 144 147 2342 2345 O
time 148 152 2346 2350 O
from 153 157 2351 2355 O
surgery 158 165 2356 2363 O

Intra 0 5 2364 2369 B-chronic_disease
- 5 6 2369 2370 I-chronic_disease
abdominal 6 15 2370 2379 I-chronic_disease
abscess 16 23 2380 2387 I-chronic_disease

Intra 0 5 2388 2393 O
- 5 6 2393 2394 O
abdominal 6 15 2394 2403 O
tumor 16 21 2404 2409 B-cancer
/ 21 22 2409 2410 O
metastases 22 32 2410 2420 B-cancer
invading 33 41 2421 2429 O
GI 42 44 2430 2432 O
mucosa 45 51 2433 2439 O

Karnofsky 0 9 2440 2449 B-clinical_variable
performance 10 21 2450 2461 I-clinical_variable
status 22 28 2462 2468 I-clinical_variable
> 29 30 2469 2470 O
= 30 31 2470 2471 O
70 32 34 2472 2474 B-lower_bound
% 34 35 2474 2475 I-lower_bound

Leukocytes 0 10 2476 2486 B-clinical_variable
> 11 12 2487 2488 O
= 12 13 2488 2489 O
3,000 14 19 2490 2495 B-lower_bound
/ 19 20 2495 2496 I-lower_bound
mcL 20 23 2496 2499 I-lower_bound

Lipase 0 6 2500 2506 B-clinical_variable
and 7 10 2507 2510 I-clinical_variable
amylase 11 18 2511 2518 I-clinical_variable
= 19 20 2519 2520 O
< 20 21 2520 2521 O
2.0 22 25 2522 2525 B-upper_bound
x 26 27 2526 2527 I-upper_bound
ULN 28 31 2528 2531 I-upper_bound
and 32 35 2532 2535 O
no 36 38 2536 2538 O
radiologic 39 49 2539 2549 O
or 50 52 2550 2552 O
clinical 53 61 2553 2561 O
evidence 62 70 2562 2570 O
of 71 73 2571 2573 O
pancreatitis 74 86 2574 2586 B-chronic_disease

Malabsorption 0 13 2587 2600 B-chronic_disease
syndrome 14 22 2601 2609 I-chronic_disease

Metastatic 0 10 2610 2620 B-cancer
disease 11 18 2621 2628 I-cancer
defined 19 26 2629 2636 O
as 27 29 2637 2639 O
new 30 33 2640 2643 O
or 34 36 2644 2646 O
progressive 37 48 2647 2658 O
lesions 49 56 2659 2666 B-cancer
on 57 59 2667 2669 O
cross 60 65 2670 2675 O
- 65 66 2675 2676 O
sectional 66 75 2676 2685 O
imaging 76 83 2686 2693 O

Myocardial 0 10 2694 2704 B-chronic_disease
infarction 11 21 2705 2715 I-chronic_disease

Non 0 3 2716 2719 O
- 3 4 2719 2720 O
resectable 4 14 2720 2730 O
squamous 15 23 2731 2739 B-cancer
cell 24 28 2740 2744 I-cancer
carcinoma 29 38 2745 2754 I-cancer
of 39 41 2755 2757 I-cancer
the 42 45 2758 2761 I-cancer
penis 46 51 2762 2767 I-cancer

One 0 3 2768 2771 O
measurable 4 14 2772 2782 O
site 15 19 2783 2787 O
of 20 22 2788 2790 O
disease 23 30 2791 2798 O
( 31 32 2799 2800 O
according 32 41 2800 2809 O
to 42 44 2810 2812 O
RECIST 45 51 2813 2819 O
criteria 52 60 2820 2828 O
) 60 61 2828 2829 O
or 62 64 2830 2832 O
bone 65 69 2833 2837 B-chronic_disease
disease 70 77 2838 2845 I-chronic_disease
by 78 80 2846 2848 O
NaF 81 84 2849 2852 O
PET 85 88 2853 2856 O
/ 88 89 2856 2857 O
CT 89 91 2857 2859 O

Other 0 5 2860 2865 O
disorders 6 15 2866 2875 O
associated 16 26 2876 2886 O
with 27 31 2887 2891 O
a 32 33 2892 2893 O
high 34 38 2894 2898 O
risk 39 43 2899 2903 O
of 44 46 2904 2906 O
fistula 47 54 2907 2914 O
formation 55 64 2915 2924 O
including 65 74 2925 2934 O
percutaneous 75 87 2935 2947 B-treatment
endoscopic 88 98 2948 2958 I-treatment
gastrostomy 99 110 2959 2970 I-treatment
( 111 112 2971 2972 I-treatment
PEG 112 115 2972 2975 I-treatment
) 115 116 2975 2976 I-treatment
tube 117 121 2977 2981 I-treatment
placement 122 131 2982 2991 I-treatment
within 132 138 2992 2998 O
3 139 140 2999 3000 B-upper_bound
months 141 147 3001 3007 I-upper_bound
before 148 154 3008 3014 I-upper_bound
the 155 158 3015 3018 O
first 159 164 3019 3024 O
dose 165 169 3025 3029 O
of 170 172 3030 3032 O
study 173 178 3033 3038 O
therapy 179 186 3039 3046 B-treatment

Patients 0 8 3047 3055 O
must 9 13 3056 3060 O
have 14 18 3061 3065 O
either 19 25 3066 3072 O
progressed 26 36 3073 3083 O
on 37 39 3084 3086 O
least 40 45 3087 3092 O
one 46 49 3093 3096 B-lower_bound
standard 50 58 3097 3105 B-treatment
therapy 59 66 3106 3113 I-treatment
or 67 69 3114 3116 O
there 70 75 3117 3122 O
must 76 80 3123 3127 O
be 81 83 3128 3130 O
no 84 86 3131 3133 O
standard 87 95 3134 3142 B-treatment
treatment 96 105 3143 3152 I-treatment
that 106 110 3153 3157 O
has 111 114 3158 3161 O
been 115 119 3162 3166 O
shown 120 125 3167 3172 O
to 126 128 3173 3175 O
prolong 129 136 3176 3183 O
survival 137 145 3184 3192 O
for 146 149 3193 3196 O
the 150 153 3197 3200 O
patient 154 161 3201 3208 O
's 161 163 3208 3210 O
disease 164 171 3211 3218 O
( 172 173 3219 3220 O
patients 173 181 3220 3228 O
with 182 186 3229 3233 O
urothelial 187 197 3234 3244 B-cancer
carcinoma 198 207 3245 3254 I-cancer
who 208 211 3255 3258 O
are 212 215 3259 3262 O
cisplatin 216 225 3263 3272 O
- 225 226 3272 3273 O
ineligible 226 236 3273 3283 O
may 237 240 3284 3287 O
receive 241 248 3288 3295 O
protocol 249 257 3296 3304 O
therapy 258 265 3305 3312 O
as 266 268 3313 3315 O
a 269 270 3316 3317 O
first 271 276 3318 3323 O
line 277 281 3324 3328 O
therapy 282 289 3329 3336 O
) 289 290 3336 3337 O
; 290 291 3337 3338 O
patients 292 300 3339 3347 O
may 301 304 3348 3351 O
have 305 309 3352 3356 O
received 310 318 3357 3365 O
any 319 322 3366 3369 O
number 323 329 3370 3376 O
of 330 332 3377 3379 O
prior 333 338 3380 3385 B-treatment
cytotoxic 339 348 3386 3395 I-treatment
agents 349 355 3396 3402 I-treatment

Patients 0 8 3403 3411 O
who 9 12 3412 3415 O
have 13 17 3416 3420 O
been 18 22 3421 3425 O
previously 23 33 3426 3436 O
treated 34 41 3437 3444 O
with 42 46 3445 3449 O
MET 47 50 3450 3453 B-treatment
or 51 53 3454 3456 O
vascular 54 62 3457 3465 B-treatment
endothelial 63 74 3466 3477 I-treatment
growth 75 81 3478 3484 I-treatment
factor 82 88 3485 3491 I-treatment
receptor 89 97 3492 3500 I-treatment
( 98 99 3501 3502 I-treatment
VEGFR 99 104 3502 3507 I-treatment
) 104 105 3507 3508 I-treatment
inhibitors 106 116 3509 3519 I-treatment
( 117 118 3520 3521 O
except 118 124 3521 3527 O
for 125 128 3528 3531 O
patients 129 137 3532 3540 O
on 138 140 3541 3543 O
renal 141 146 3544 3549 B-cancer
cell 147 151 3550 3554 I-cancer
cancer 152 158 3555 3561 I-cancer
[ 159 160 3562 3563 I-cancer
RCC 160 163 3563 3566 I-cancer
] 163 164 3566 3567 I-cancer
cohort 165 171 3568 3574 O
) 171 172 3574 3575 O
are 173 176 3576 3579 O
not 177 180 3580 3583 O
eligible 181 189 3584 3592 O
for 190 193 3593 3596 O
the 194 197 3597 3600 O
expansion 198 207 3601 3610 O
cohorts 208 215 3611 3618 O
but 216 219 3619 3622 O
can 220 223 3623 3626 O
enroll 224 230 3627 3633 O
in 231 233 3634 3636 O
the 234 237 3637 3640 O
phase 238 243 3641 3646 O
I 244 245 3647 3648 O
portion 246 253 3649 3656 O

Patients 0 8 3657 3665 O
with 9 13 3666 3670 O
urothelial 14 24 3671 3681 B-cancer
cancer 25 31 3682 3688 I-cancer
or 32 34 3689 3691 O
renal 35 40 3692 3697 B-cancer
cell 41 45 3698 3702 I-cancer
carcinoma 46 55 3703 3712 I-cancer
must 56 60 3713 3717 O
have 61 65 3718 3722 O
progressive 66 77 3723 3734 O
metastatic 78 88 3735 3745 B-cancer
disease 89 96 3746 3753 I-cancer
defined 97 104 3754 3761 O
as 105 107 3762 3764 O
new 108 111 3765 3768 O
or 112 114 3769 3771 O
progressive 115 126 3772 3783 O
lesions 127 134 3784 3791 B-cancer
on 135 137 3792 3794 O
cross 138 143 3795 3800 O
- 143 144 3800 3801 O
sectional 144 153 3801 3810 O
imaging 154 161 3811 3818 O

Platelets 0 9 3819 3828 B-clinical_variable
> 10 11 3829 3830 O
= 11 12 3830 3831 O
75,000 13 19 3832 3838 B-lower_bound
/ 19 20 3838 3839 I-lower_bound
mcL 20 23 3839 3842 I-lower_bound

Prior 0 5 3843 3848 B-treatment
treatment 6 15 3849 3858 I-treatment
with 16 20 3859 3863 O
any 21 24 3864 3867 B-treatment
therapy 25 32 3868 3875 I-treatment
on 33 35 3876 3878 O
the 36 39 3879 3882 O
programmed 40 50 3883 3893 O
cell 51 55 3894 3898 O
death 56 61 3899 3904 O
1 62 63 3905 3906 O
( 64 65 3907 3908 O
PD-1)/PD 65 73 3908 3916 O
- 73 74 3916 3917 O
L1 74 76 3917 3919 O
axis 77 81 3920 3924 O
or 82 84 3925 3927 O
anti 85 89 3928 3932 O
- 89 90 3932 3933 O
cytotoxic 90 99 3933 3942 O
T 100 101 3943 3944 O
- 101 102 3944 3945 O
lymphocyte 102 112 3945 3955 O
- 112 113 3955 3956 O
associated 113 123 3956 3966 O
protein 124 131 3967 3974 O
4 132 133 3975 3976 O
( 134 135 3977 3978 O
CTLA-4 135 141 3978 3984 O
) 141 142 3984 3985 O
inhibitors 143 153 3986 3996 O
unless 154 160 3997 4003 O
enrolling 161 170 4004 4013 O
the 171 174 4014 4017 O
urothelial 175 185 4018 4028 B-cancer
carcinoma 186 195 4029 4038 I-cancer
with 196 200 4039 4043 O
previous 201 209 4044 4052 O
checkpoint 210 220 4053 4063 O
inhibition 221 231 4064 4074 O
therapy 232 239 4075 4082 O
expansion 240 249 4083 4092 O
cohort 250 256 4093 4099 O

Serious 0 7 4100 4107 O
non 8 11 4108 4111 B-chronic_disease
- 11 12 4111 4112 I-chronic_disease
healing 12 19 4112 4119 I-chronic_disease
wound 20 25 4120 4125 I-chronic_disease
/ 25 26 4125 4126 O
ulcer 26 31 4126 4131 B-chronic_disease
/ 31 32 4131 4132 O
bone 32 36 4132 4136 O
fracture 37 45 4137 4145 O
within 46 52 4146 4152 O
28 53 55 4153 4155 B-upper_bound
days 56 60 4156 4160 I-upper_bound
before 61 67 4161 4167 I-upper_bound
the 68 71 4168 4171 O
first 72 77 4172 4177 O
dose 78 82 4178 4182 O
of 83 85 4183 4185 O
study 86 91 4186 4191 B-treatment
treatment 92 101 4192 4201 I-treatment

Serum 0 5 4202 4207 B-clinical_variable
albumin 6 13 4208 4215 I-clinical_variable
> 14 15 4216 4217 O
= 15 16 4217 4218 O
2.8 17 20 4219 4222 B-lower_bound
g 21 22 4223 4224 I-lower_bound
/ 22 23 4224 4225 I-lower_bound
dL 23 25 4225 4227 I-lower_bound

Severe 0 6 4228 4234 O
active 7 13 4235 4241 O
infection 14 23 4242 4251 B-chronic_disease
requiring 24 33 4252 4261 O
systemic 34 42 4262 4270 B-treatment
treatment 43 52 4271 4280 I-treatment
within 53 59 4281 4287 O
14 60 62 4288 4290 B-upper_bound
days 63 67 4291 4295 I-upper_bound
before 68 74 4296 4302 I-upper_bound
the 75 78 4303 4306 O
first 79 84 4307 4312 O
dose 85 89 4313 4317 O
of 90 92 4318 4320 O
study 93 98 4321 4326 O
treatment 99 108 4327 4336 O

Squamous 0 8 4337 4345 B-cancer
or 9 11 4346 4348 O
small 12 17 4349 4354 B-cancer
cell 18 22 4355 4359 I-cancer
carcinoma 23 32 4360 4369 I-cancer
of 33 35 4370 4372 I-cancer
the 36 39 4373 4376 I-cancer
bladder 40 47 4377 4384 I-cancer
, 47 48 4384 4385 O
renal 49 54 4386 4391 B-cancer
medullary 55 64 4392 4401 I-cancer
carcinoma 65 74 4402 4411 I-cancer
( 75 76 4412 4413 I-cancer
RMC 76 79 4413 4416 I-cancer
) 79 80 4416 4417 I-cancer
, 80 81 4417 4418 O
sarcomatoid 82 93 4419 4430 B-cancer
bladder 94 101 4431 4438 I-cancer
and 102 105 4439 4442 O
renal 106 111 4443 4448 B-cancer
cell 112 116 4449 4453 I-cancer
carcinomas 117 127 4454 4464 I-cancer
, 127 128 4464 4465 O
plasmacytoid 129 141 4466 4478 B-cancer
carcinoma 142 151 4479 4488 I-cancer
of 152 154 4489 4491 I-cancer
the 155 158 4492 4495 I-cancer
bladder 159 166 4496 4503 I-cancer
or 167 169 4504 4506 O
other 170 175 4507 4512 O
rare 176 180 4513 4517 O
bladder 181 188 4518 4525 O
/ 188 189 4525 4526 O
kidney 189 195 4526 4532 B-cancer
cancer 196 202 4533 4539 I-cancer
histology 203 212 4540 4549 O

Stroke 0 6 4550 4556 B-chronic_disease
( 7 8 4557 4558 O
including 8 17 4558 4567 O
transient 18 27 4568 4577 B-chronic_disease
ischemic 28 36 4578 4586 I-chronic_disease
attack 37 43 4587 4593 I-chronic_disease
[ 44 45 4594 4595 I-chronic_disease
TIA 45 48 4595 4598 I-chronic_disease
] 48 49 4598 4599 I-chronic_disease
, 49 50 4599 4600 O
or 51 53 4601 4603 O
other 54 59 4604 4609 O
ischemic 60 68 4610 4618 O
event 69 74 4619 4624 O
) 74 75 4624 4625 O

The 0 3 4626 4629 O
effects 4 11 4630 4637 O
of 12 14 4638 4640 O
the 15 18 4641 4644 O
drugs 19 24 4645 4650 O
used 25 29 4651 4655 O
in 30 32 4656 4658 O
this 33 37 4659 4663 O
trial 38 43 4664 4669 O
on 44 46 4670 4672 O
the 47 50 4673 4676 O
developing 51 61 4677 4687 O
human 62 67 4688 4693 O
fetus 68 73 4694 4699 O
are 74 77 4700 4703 O
unknown 78 85 4704 4711 O
; 85 86 4711 4712 O
however 87 94 4713 4720 O
, 94 95 4720 4721 O
cabozantinib 96 108 4722 4734 B-treatment
was 109 112 4735 4738 O
embryolethal 113 125 4739 4751 O
in 126 128 4752 4754 O
rats 129 133 4755 4759 O
at 134 136 4760 4762 O
exposures 137 146 4763 4772 O
below 147 152 4773 4778 O
the 153 156 4779 4782 O
140 157 160 4783 4786 B-upper_bound
mg 160 162 4786 4788 I-upper_bound
dose 163 167 4789 4793 O
in 168 170 4794 4796 O
the 171 174 4797 4800 O
label 175 180 4801 4806 O
, 180 181 4806 4807 O
with 182 186 4808 4812 O
increased 187 196 4813 4822 O
incidences 197 207 4823 4833 O
of 208 210 4834 4836 O
skeletal 211 219 4837 4845 O
variations 220 230 4846 4856 O
in 231 233 4857 4859 O
rats 234 238 4860 4864 O
and 239 242 4865 4868 O
visceral 243 251 4869 4877 O
variations 252 262 4878 4888 O
and 263 266 4889 4892 O
malformations 267 280 4893 4906 O
in 281 283 4907 4909 O
rabbits 284 291 4910 4917 O
; 291 292 4917 4918 O
for 293 296 4919 4922 O
this 297 301 4923 4927 O
reason 302 308 4928 4934 O
and 309 312 4935 4938 O
because 313 320 4939 4946 O
tyrosine 321 329 4947 4955 B-treatment
kinase 330 336 4956 4962 I-treatment
inhibitors 337 347 4963 4973 I-treatment
agents 348 354 4974 4980 I-treatment
as 355 357 4981 4983 O
well 358 362 4984 4988 O
as 363 365 4989 4991 O
other 366 371 4992 4997 O
therapeutic 372 383 4998 5009 B-treatment
agents 384 390 5010 5016 I-treatment
used 391 395 5017 5021 O
in 396 398 5022 5024 O
this 399 403 5025 5029 O
trial 404 409 5030 5035 O
are 410 413 5036 5039 O
known 414 419 5040 5045 O
to 420 422 5046 5048 O
be 423 425 5049 5051 O
teratogenic 426 437 5052 5063 B-treatment
, 437 438 5063 5064 O
women 439 444 5065 5070 B-gender
of 445 447 5071 5073 O
child 448 453 5074 5079 O
- 453 454 5079 5080 O
bearing 454 461 5080 5087 O
potential 462 471 5088 5097 O
and 472 475 5098 5101 O
men 476 479 5102 5105 O
must 480 484 5106 5110 O
agree 485 490 5111 5116 B-contraception_consent
to 491 493 5117 5119 I-contraception_consent
use 494 497 5120 5123 I-contraception_consent
adequate 498 506 5124 5132 I-contraception_consent
contraception 507 520 5133 5146 I-contraception_consent
, 520 521 5146 5147 O
as 522 524 5148 5150 O
defined 525 532 5151 5158 O
below 533 538 5159 5164 O
, 538 539 5164 5165 O
prior 540 545 5166 5171 O
to 546 548 5172 5174 O
study 549 554 5175 5180 O
entry 555 560 5181 5186 O
and 561 564 5187 5190 O
for 565 568 5191 5194 O
the 569 572 5195 5198 O
duration 573 581 5199 5207 O
of 582 584 5208 5210 O
study 585 590 5211 5216 O
participation 591 604 5217 5230 O
; 604 605 5230 5231 O
should 606 612 5232 5238 O
a 613 614 5239 5240 O
woman 615 620 5241 5246 B-gender
become 621 627 5247 5253 O
pregnant 628 636 5254 5262 B-pregnancy
or 637 639 5263 5265 O
suspect 640 647 5266 5273 B-pregnancy
she 648 651 5274 5277 I-pregnancy
is 652 654 5278 5280 I-pregnancy
pregnant 655 663 5281 5289 I-pregnancy
while 664 669 5290 5295 O
she 670 673 5296 5299 O
is 674 676 5300 5302 O
participating 677 690 5303 5316 O
in 691 693 5317 5319 O
this 694 698 5320 5324 O
study 699 704 5325 5330 O
, 704 705 5330 5331 O
she 706 709 5332 5335 O
should 710 716 5336 5342 O
inform 717 723 5343 5349 O
her 724 727 5350 5353 O
treating 728 736 5354 5362 O
physician 737 746 5363 5372 O
immediately 747 758 5373 5384 O
; 758 759 5384 5385 O
men 760 763 5386 5389 O
treated 764 771 5390 5397 O
or 772 774 5398 5400 O
enrolled 775 783 5401 5409 O
on 784 786 5410 5412 O
this 787 791 5413 5417 O
protocol 792 800 5418 5426 O
must 801 805 5427 5431 O
also 806 810 5432 5436 O
agree 811 816 5437 5442 O
to 817 819 5443 5445 O
use 820 823 5446 5449 O
adequate 824 832 5450 5458 O
contraception 833 846 5459 5472 O
prior 847 852 5473 5478 O
to 853 855 5479 5481 O
the 856 859 5482 5485 O
study 860 865 5486 5491 O
, 865 866 5491 5492 O
for 867 870 5493 5496 O
the 871 874 5497 5500 O
duration 875 883 5501 5509 O
of 884 886 5510 5512 O
study 887 892 5513 5518 O
participation 893 906 5519 5532 O
, 906 907 5532 5533 O
and 908 911 5534 5537 O
7 912 913 5538 5539 B-upper_bound
months 914 920 5540 5546 I-upper_bound
after 921 926 5547 5552 O
completion 927 937 5553 5563 O
of 938 940 5564 5566 O
all 941 944 5567 5570 O
study 945 950 5571 5576 B-treatment
medications 951 962 5577 5588 I-treatment
; 962 963 5588 5589 O
women 964 969 5590 5595 O
treated 970 977 5596 5603 O
or 978 980 5604 5606 O
enrolled 981 989 5607 5615 O
on 990 992 5616 5618 O
this 993 997 5619 5623 O
protocol 998 1006 5624 5632 O
must 1007 1011 5633 5637 O
also 1012 1016 5638 5642 O
agree 1017 1022 5643 5648 O
to 1023 1025 5649 5651 O
use 1026 1029 5652 5655 O
adequate 1030 1038 5656 5664 O
contraception 1039 1052 5665 5678 O
prior 1053 1058 5679 5684 O
to 1059 1061 5685 5687 O
the 1062 1065 5688 5691 O
study 1066 1071 5692 5697 O
, 1071 1072 5697 5698 O
for 1073 1076 5699 5702 O
the 1077 1080 5703 5706 O
duration 1081 1089 5707 5715 O
of 1090 1092 5716 5718 O
study 1093 1098 5719 5724 O
participation 1099 1112 5725 5738 O
, 1112 1113 5738 5739 O
and 1114 1117 5740 5743 O
for 1118 1121 5744 5747 O
5 1122 1123 5748 5749 B-upper_bound
months 1124 1130 5750 5756 I-upper_bound
after 1131 1136 5757 5762 O
completion 1137 1147 5763 5773 O
of 1148 1150 5774 5776 O
all 1151 1154 5777 5780 O
study 1155 1160 5781 5786 O
medications 1161 1172 5787 5798 O

The 0 3 5799 5802 O
subject 4 11 5803 5810 O
has 12 15 5811 5814 O
a 16 17 5815 5816 O
corrected 18 27 5817 5826 O
QT 28 30 5827 5829 B-clinical_variable
interval 31 39 5830 5838 I-clinical_variable
calculated 40 50 5839 5849 I-clinical_variable
by 51 53 5850 5852 I-clinical_variable
the 54 57 5853 5856 I-clinical_variable
Fridericia 58 68 5857 5867 I-clinical_variable
formula 69 76 5868 5875 I-clinical_variable
( 77 78 5876 5877 I-clinical_variable
QTcF 78 82 5877 5881 I-clinical_variable
) 82 83 5881 5882 I-clinical_variable
> 84 85 5883 5884 O
500 86 89 5885 5888 B-lower_bound
ms 90 92 5889 5891 I-lower_bound
within 93 99 5892 5898 O
28 100 102 5899 5901 B-upper_bound
days 103 107 5902 5906 I-upper_bound
before 108 114 5907 5913 I-upper_bound
randomization 115 128 5914 5927 O

The 0 3 5928 5931 O
subject 4 11 5932 5939 O
has 12 15 5940 5943 O
evidence 16 24 5944 5952 O
of 25 27 5953 5955 O
tumor 28 33 5956 5961 B-cancer
invading 34 42 5962 5970 O
the 43 46 5971 5974 O
gastrointestinal 47 63 5975 5991 O
( 64 65 5992 5993 O
GI 65 67 5993 5995 O
) 67 68 5995 5996 O
tract 69 74 5997 6002 O
( 75 76 6003 6004 O
esophagus 76 85 6004 6013 B-cancer
, 85 86 6013 6014 O
stomach 87 94 6015 6022 B-cancer
, 94 95 6022 6023 O
small 96 101 6024 6029 B-cancer
or 102 104 6030 6032 I-cancer
large 105 110 6033 6038 I-cancer
bowel 111 116 6039 6044 I-cancer
, 116 117 6044 6045 O
rectum 118 124 6046 6052 B-cancer
or 125 127 6053 6055 O
anus 128 132 6056 6060 B-cancer
) 132 133 6060 6061 O
, 133 134 6061 6062 O
or 135 137 6063 6065 O
any 138 141 6066 6069 O
evidence 142 150 6070 6078 O
of 151 153 6079 6081 O
endotracheal 154 166 6082 6094 B-cancer
or 167 169 6095 6097 O
endobronchial 170 183 6098 6111 B-cancer
tumor 184 189 6112 6117 I-cancer
within 190 196 6118 6124 O
28 197 199 6125 6127 B-upper_bound
days 200 204 6128 6132 I-upper_bound
before 205 211 6133 6139 I-upper_bound
the 212 215 6140 6143 O
first 216 221 6144 6149 O
dose 222 226 6150 6154 O
of 227 229 6155 6157 O
cabozantinib 230 242 6158 6170 B-treatment

The 0 3 6171 6174 O
subject 4 11 6175 6182 O
has 12 15 6183 6186 O
not 16 19 6187 6190 O
recovered 20 29 6191 6200 O
to 30 32 6201 6203 O
baseline 33 41 6204 6212 O
or 42 44 6213 6215 O
Common 45 51 6216 6222 B-clinical_variable
Terminology 52 63 6223 6234 I-clinical_variable
Criteria 64 72 6235 6243 I-clinical_variable
for 73 76 6244 6247 I-clinical_variable
Adverse 77 84 6248 6255 I-clinical_variable
Events 85 91 6256 6262 I-clinical_variable
( 92 93 6263 6264 I-clinical_variable
CTCAE 93 98 6264 6269 I-clinical_variable
) 98 99 6269 6270 I-clinical_variable
= 100 101 6271 6272 O
< 101 102 6272 6273 O
grade 103 108 6274 6279 B-upper_bound
1 109 110 6280 6281 I-upper_bound
from 111 115 6282 6286 O
toxicity 116 124 6287 6295 O
due 125 128 6296 6299 O
to 129 131 6300 6302 O
all 132 135 6303 6306 O
prior 136 141 6307 6312 B-treatment
therapies 142 151 6313 6322 I-treatment
except 152 158 6323 6329 O
alopecia 159 167 6330 6338 B-chronic_disease
and 168 171 6339 6342 O
other 172 177 6343 6348 O
non 178 181 6349 6352 O
- 181 182 6352 6353 O
clinically 182 192 6353 6363 O
significant 193 204 6364 6375 O
adverse 205 212 6376 6383 O
events 213 219 6384 6390 O
( 220 221 6391 6392 O
AEs 221 224 6392 6395 O
) 224 225 6395 6396 O
defined 226 233 6397 6404 O
as 234 236 6405 6407 O
lab 237 240 6408 6411 O
elevation 241 250 6412 6421 O
with 251 255 6422 6426 O
no 256 258 6427 6429 O
associated 259 269 6430 6440 O
symptoms 270 278 6441 6449 O
or 279 281 6450 6452 O
sequelae 282 290 6453 6461 B-chronic_disease

The 0 3 6462 6465 O
subject 4 11 6466 6473 O
has 12 15 6474 6477 O
prothrombin 16 27 6478 6489 B-clinical_variable
time 28 32 6490 6494 I-clinical_variable
( 33 34 6495 6496 I-clinical_variable
PT)/international 34 51 6496 6513 I-clinical_variable
normalized 52 62 6514 6524 I-clinical_variable
ratio 63 68 6525 6530 I-clinical_variable
( 69 70 6531 6532 I-clinical_variable
INR 70 73 6532 6535 I-clinical_variable
) 73 74 6535 6536 I-clinical_variable
or 75 77 6537 6539 O
partial 78 85 6540 6547 B-clinical_variable
thromboplastin 86 100 6548 6562 I-clinical_variable
time 101 105 6563 6567 I-clinical_variable
( 106 107 6568 6569 I-clinical_variable
PTT 107 110 6569 6572 I-clinical_variable
) 110 111 6572 6573 I-clinical_variable
test 112 116 6574 6578 I-clinical_variable
> 117 118 6579 6580 O
= 118 119 6580 6581 O
1.5 120 123 6582 6585 B-lower_bound
x 124 125 6586 6587 I-lower_bound
the 126 129 6588 6591 I-lower_bound
laboratory 130 140 6592 6602 I-lower_bound
ULN 141 144 6603 6606 I-lower_bound
within 145 151 6607 6613 O
7 152 153 6614 6615 B-upper_bound
days 154 158 6616 6620 I-upper_bound
before 159 165 6621 6627 I-upper_bound
the 166 169 6628 6631 O
first 170 175 6632 6637 O
dose 176 180 6638 6642 O
of 181 183 6643 6645 O
study 184 189 6646 6651 O
treatment 190 199 6652 6661 B-treatment

The 0 3 6662 6665 O
subject 4 11 6666 6673 O
has 12 15 6674 6677 O
received 16 24 6678 6686 O
any 25 28 6687 6690 O
other 29 34 6691 6696 O
type 35 39 6697 6701 O
of 40 42 6702 6704 O
investigational 43 58 6705 6720 B-treatment
agent 59 64 6721 6726 I-treatment
within 65 71 6727 6733 O
28 72 74 6734 6736 B-upper_bound
days 75 79 6737 6741 I-upper_bound
before 80 86 6742 6748 I-upper_bound
the 87 90 6749 6752 O
first 91 96 6753 6758 O
dose 97 101 6759 6763 O
of 102 104 6764 6766 O
study 105 110 6767 6772 O
treatment 111 120 6773 6782 B-treatment

The 0 3 6783 6786 O
subject 4 11 6787 6794 O
has 12 15 6795 6798 O
received 16 24 6799 6807 O
cytotoxic 25 34 6808 6817 B-treatment
chemotherapy 35 47 6818 6830 I-treatment
( 48 49 6831 6832 O
including 49 58 6832 6841 O
investigational 59 74 6842 6857 B-treatment
cytotoxic 75 84 6858 6867 I-treatment
chemotherapy 85 97 6868 6880 I-treatment
) 97 98 6880 6881 O
or 99 101 6882 6884 O
biologic 102 110 6885 6893 B-treatment
agents 111 117 6894 6900 I-treatment
( 118 119 6901 6902 O
e.g. 119 123 6902 6906 O
, 123 124 6906 6907 O
cytokines 125 134 6908 6917 B-treatment
or 135 137 6918 6920 O
antibodies 138 148 6921 6931 B-treatment
) 148 149 6931 6932 O
within 150 156 6933 6939 O
3 157 158 6940 6941 B-upper_bound
weeks 159 164 6942 6947 I-upper_bound
, 164 165 6947 6948 O
or 166 168 6949 6951 O
nitrosoureas 169 181 6952 6964 B-treatment
/ 181 182 6964 6965 O
mitomycin 182 191 6965 6974 B-treatment
C 192 193 6975 6976 I-treatment
within 194 200 6977 6983 O
6 201 202 6984 6985 B-upper_bound
weeks 203 208 6986 6991 I-upper_bound
before 209 215 6992 6998 O
the 216 219 6999 7002 O
first 220 225 7003 7008 O
dose 226 230 7009 7013 O
of 231 233 7014 7016 O
study 234 239 7017 7022 O
treatment 240 249 7023 7032 B-treatment

The 0 3 7033 7036 O
subject 4 11 7037 7044 O
has 12 15 7045 7048 O
received 16 24 7049 7057 O
prior 25 30 7058 7063 B-treatment
treatment 31 40 7064 7073 I-treatment
with 41 45 7074 7078 I-treatment
a 46 47 7079 7080 I-treatment
small 48 53 7081 7086 I-treatment
molecule 54 62 7087 7095 I-treatment
kinase 63 69 7096 7102 I-treatment
inhibitor 70 79 7103 7112 I-treatment
within 80 86 7113 7119 O
14 87 89 7120 7122 B-upper_bound
days 90 94 7123 7127 I-upper_bound
or 95 97 7128 7130 O
five 98 102 7131 7135 B-upper_bound
half 103 107 7136 7140 O
- 107 108 7140 7141 O
lives 108 113 7141 7146 O
of 114 116 7147 7149 O
the 117 120 7150 7153 O
compound 121 129 7154 7162 O
or 130 132 7163 7165 O
active 133 139 7166 7172 O
metabolites 140 151 7173 7184 O
, 151 152 7184 7185 O
whichever 153 162 7186 7195 O
is 163 165 7196 7198 O
longer 166 172 7199 7205 O
, 172 173 7205 7206 O
before 174 180 7207 7213 O
the 181 184 7214 7217 O
first 185 190 7218 7223 O
dose 191 195 7224 7228 O
of 196 198 7229 7231 O
study 199 204 7232 7237 B-treatment
treatment 205 214 7238 7247 I-treatment

The 0 3 7248 7251 O
subject 4 11 7252 7259 O
has 12 15 7260 7263 O
received 16 24 7264 7272 O
prior 25 30 7273 7278 B-treatment
treatment 31 40 7279 7288 I-treatment
with 41 45 7289 7293 I-treatment
hormonal 46 54 7294 7302 I-treatment
therapy 55 62 7303 7310 I-treatment
within 63 69 7311 7317 O
14 70 72 7318 7320 B-upper_bound
days 73 77 7321 7325 I-upper_bound
or 78 80 7326 7328 O
five 81 85 7329 7333 B-upper_bound
half 86 90 7334 7338 I-upper_bound
- 90 91 7338 7339 I-upper_bound
lives 91 96 7339 7344 I-upper_bound
of 97 99 7345 7347 O
the 100 103 7348 7351 O
compound 104 112 7352 7360 O
or 113 115 7361 7363 O
active 116 122 7364 7370 O
metabolites 123 134 7371 7382 O
, 134 135 7382 7383 O
whichever 136 145 7384 7393 O
is 146 148 7394 7396 O
longer 149 155 7397 7403 O
, 155 156 7403 7404 O
before 157 163 7405 7411 O
the 164 167 7412 7415 O
first 168 173 7416 7421 O
dose 174 178 7422 7426 O
of 179 181 7427 7429 O
study 182 187 7430 7435 O
treatment 188 197 7436 7445 O
; 197 198 7445 7446 O
subjects 199 207 7447 7455 O
receiving 208 217 7456 7465 O
gonadotropin 218 230 7466 7478 B-treatment
- 230 231 7478 7479 I-treatment
releasing 231 240 7479 7488 I-treatment
hormone 241 248 7489 7496 I-treatment
( 249 250 7497 7498 I-treatment
GnRH 250 254 7498 7502 I-treatment
) 254 255 7502 7503 I-treatment
agonists 256 264 7504 7512 I-treatment
and 265 268 7513 7516 I-treatment
antagonists 269 280 7517 7528 I-treatment
are 281 284 7529 7532 O
allowed 285 292 7533 7540 O
to 293 295 7541 7543 O
participate 296 307 7544 7555 O

The 0 3 7556 7559 O
subject 4 11 7560 7567 O
has 12 15 7568 7571 O
received 16 24 7572 7580 O
radiation 25 34 7581 7590 B-treatment
therapy 35 42 7591 7598 I-treatment

The 0 3 7599 7602 O
subject 4 11 7603 7610 O
has 12 15 7611 7614 O
received 16 24 7615 7623 O
radionuclide 25 37 7624 7636 B-treatment
treatment 38 47 7637 7646 I-treatment
within 48 54 7647 7653 O
6 55 56 7654 7655 B-upper_bound
weeks 57 62 7656 7661 I-upper_bound
of 63 65 7662 7664 O
the 66 69 7665 7668 O
first 70 75 7669 7674 O
dose 76 80 7675 7679 O
of 81 83 7680 7682 O
study 84 89 7683 7688 O
treatment 90 99 7689 7698 O

The 0 3 7699 7702 O
subject 4 11 7703 7710 O
has 12 15 7711 7714 O
tumor 16 21 7715 7720 B-cancer
invading 22 30 7721 7729 O
any 31 34 7730 7733 O
major 35 40 7734 7739 O
blood 41 46 7740 7745 O
vessels 47 54 7746 7753 O

The 0 3 7754 7757 O
subject 4 11 7758 7765 O
requires 12 20 7766 7774 O
concomitant 21 32 7775 7786 B-treatment
treatment 33 42 7787 7796 I-treatment
, 42 43 7796 7797 O
in 44 46 7798 7800 O
therapeutic 47 58 7801 7812 O
doses 59 64 7813 7818 O
, 64 65 7818 7819 O
with 66 70 7820 7824 O
anticoagulants 71 85 7825 7839 B-treatment
such 86 90 7840 7844 O
as 91 93 7845 7847 O
warfarin 94 102 7848 7856 B-treatment
or 103 105 7857 7859 O
warfarin 106 114 7860 7868 O
- 114 115 7868 7869 O
related 115 122 7869 7876 O
agents 123 129 7877 7883 O
, 129 130 7883 7884 O
thrombin 131 139 7885 7893 B-treatment
or 140 142 7894 7896 O
factor 143 149 7897 7903 B-treatment
Xa 150 152 7904 7906 I-treatment
inhibitors 153 163 7907 7917 I-treatment
; 163 164 7917 7918 O
aspirin 165 172 7919 7926 B-treatment
( 173 174 7927 7928 O
up 174 176 7928 7930 O
to 177 179 7931 7933 O
325 180 183 7934 7937 B-upper_bound
mg 184 186 7938 7940 I-upper_bound
/ 186 187 7940 7941 I-upper_bound
day 187 190 7941 7944 I-upper_bound
) 190 191 7944 7945 O
, 191 192 7945 7946 O
low 193 196 7947 7950 B-treatment
- 196 197 7950 7951 I-treatment
dose 197 201 7951 7955 I-treatment
warfarin 202 210 7956 7964 I-treatment
(= 211 213 7965 7967 O
< 213 214 7967 7968 O
1 215 216 7969 7970 B-upper_bound
mg 217 219 7971 7973 I-upper_bound
/ 219 220 7973 7974 I-upper_bound
day 220 223 7974 7977 I-upper_bound
) 223 224 7977 7978 O
, 224 225 7978 7979 O
prophylactic 226 238 7980 7992 B-treatment
and 239 242 7993 7996 I-treatment
therapeutic 243 254 7997 8008 I-treatment
low 255 258 8009 8012 I-treatment
molecular 259 268 8013 8022 I-treatment
weight 269 275 8023 8029 I-treatment
heparin 276 283 8030 8037 I-treatment
( 284 285 8038 8039 I-treatment
LMWH 285 289 8039 8043 I-treatment
) 289 290 8043 8044 I-treatment

To 0 2 8045 8047 O
any 3 6 8048 8051 O
other 7 12 8052 8057 O
site(s 13 19 8058 8064 O
) 19 20 8064 8065 O
within 21 27 8066 8072 O
28 28 30 8073 8075 B-upper_bound
days 31 35 8076 8080 I-upper_bound
before 36 42 8081 8087 O
the 43 46 8088 8091 O
first 47 52 8092 8097 O
dose 53 57 8098 8102 O
of 58 60 8103 8105 O
study 61 66 8106 8111 O
treatment 67 76 8112 8121 B-treatment

To 0 2 8122 8124 O
bone 3 7 8125 8129 O
or 8 10 8130 8132 O
brain 11 16 8133 8138 B-cancer
metastasis 17 27 8139 8149 I-cancer
within 28 34 8150 8156 O
3 35 36 8157 8158 B-upper_bound
weeks 37 42 8159 8164 I-upper_bound
before 43 49 8165 8171 O
the 50 53 8172 8175 O
first 54 59 8176 8181 O
dose 60 64 8182 8186 O
of 65 67 8187 8189 O
study 68 73 8190 8195 B-treatment
treatment 74 83 8196 8205 I-treatment

To 0 2 8206 8208 O
the 3 6 8209 8212 O
thoracic 7 15 8213 8221 O
cavity 16 22 8222 8228 O
or 23 25 8229 8231 O
abdomen 26 33 8232 8239 O
within 34 40 8240 8246 O
3 41 42 8247 8248 B-upper_bound
months 43 49 8249 8255 I-upper_bound
before 50 56 8256 8262 O
the 57 60 8263 8266 O
first 61 66 8267 8272 O
dose 67 71 8273 8277 O
of 72 74 8278 8280 O
study 75 80 8281 8286 B-treatment
treatment 81 90 8287 8296 I-treatment
, 90 91 8296 8297 O
or 92 94 8298 8300 O
has 95 98 8301 8304 O
ongoing 99 106 8305 8312 O
complications 107 120 8313 8326 O
, 120 121 8326 8327 O
or 122 124 8328 8330 O
is 125 127 8331 8333 O
without 128 135 8334 8341 O
complete 136 144 8342 8350 O
recovery 145 153 8351 8359 O
and 154 157 8360 8363 O
healing 158 165 8364 8371 O
from 166 170 8372 8376 O
prior 171 176 8377 8382 B-treatment
radiation 177 186 8383 8392 I-treatment
therapy 187 194 8393 8400 I-treatment

Total 0 5 8401 8406 B-clinical_variable
bilirubin 6 15 8407 8416 I-clinical_variable
= 16 17 8417 8418 O
< 17 18 8418 8419 O
1.5 19 22 8420 8423 B-upper_bound
x 23 24 8424 8425 I-upper_bound
upper 25 30 8426 8431 I-upper_bound
limit 31 36 8432 8437 I-upper_bound
of 37 39 8438 8440 I-upper_bound
normal 40 46 8441 8447 I-upper_bound
( 47 48 8448 8449 I-upper_bound
ULN 48 51 8449 8452 I-upper_bound
) 51 52 8452 8453 I-upper_bound
; 52 53 8453 8454 O
for 54 57 8455 8458 O
subjects 58 66 8459 8467 O
with 67 71 8468 8472 O
known 72 77 8473 8478 O
Gilbert 78 85 8479 8486 B-chronic_disease
's 85 87 8486 8488 I-chronic_disease
disease 88 95 8489 8496 I-chronic_disease
or 96 98 8497 8499 O
similar 99 106 8500 8507 O
syndrome 107 115 8508 8516 O
with 116 120 8517 8521 O
slow 121 125 8522 8526 O
conjugation 126 137 8527 8538 O
of 138 140 8539 8541 O
bilirubin 141 150 8542 8551 O
, 150 151 8551 8552 O
total 152 157 8553 8558 B-clinical_variable
bilirubin 158 167 8559 8568 I-clinical_variable
= 168 169 8569 8570 O
< 169 170 8570 8571 O
3.0 171 174 8572 8575 B-upper_bound
mg 175 177 8576 8578 I-upper_bound
/ 177 178 8578 8579 I-upper_bound
dL 178 180 8579 8581 I-upper_bound

Unstable 0 8 8582 8590 B-chronic_disease
angina 9 15 8591 8597 I-chronic_disease
pectoris 16 24 8598 8606 I-chronic_disease

Urine 0 5 8607 8612 B-clinical_variable
protein 6 13 8613 8620 I-clinical_variable
/ 13 14 8620 8621 I-clinical_variable
creatinine 14 24 8621 8631 I-clinical_variable
ratio 25 30 8632 8637 I-clinical_variable
( 31 32 8638 8639 I-clinical_variable
UPCR 32 36 8639 8643 I-clinical_variable
) 36 37 8643 8644 I-clinical_variable
= 38 39 8645 8646 O
< 39 40 8646 8647 O
2 41 42 8648 8649 B-upper_bound

Urothelial 0 10 8650 8660 B-cancer
carcinoma 11 20 8661 8670 I-cancer
of 21 23 8671 8673 I-cancer
the 24 27 8674 8677 I-cancer
bladder 28 35 8678 8685 I-cancer
, 35 36 8685 8686 O
urethra 37 44 8687 8694 B-cancer
, 44 45 8694 8695 O
ureter 46 52 8696 8702 B-cancer
, 52 53 8702 8703 O
renal 54 59 8704 8709 B-cancer
pelvis 60 66 8710 8716 I-cancer

Women 0 5 8717 8722 B-gender
of 6 8 8723 8725 O
childbearing 9 21 8726 8738 O
potential 22 31 8739 8748 O
must 32 36 8749 8753 O
have 37 41 8754 8758 O
a 42 43 8759 8760 O
negative 44 52 8761 8769 B-pregnancy
pregnancy 53 62 8770 8779 I-pregnancy
test 63 67 8780 8784 O
at 68 70 8785 8787 O
screening 71 80 8788 8797 O
; 80 81 8797 8798 O
women 82 87 8799 8804 B-gender
of 88 90 8805 8807 O
childbearing 91 103 8808 8820 O
potential 104 113 8821 8830 O
include 114 121 8831 8838 O
women 122 127 8839 8844 O
who 128 131 8845 8848 O
have 132 136 8849 8853 O
experienced 137 148 8854 8865 O
menarche 149 157 8866 8874 O
and 158 161 8875 8878 O
who 162 165 8879 8882 O
have 166 170 8883 8887 O
not 171 174 8888 8891 O
undergone 175 184 8892 8901 O
successful 185 195 8902 8912 O
surgical 196 204 8913 8921 O
sterilization 205 218 8922 8935 O
( 219 220 8936 8937 O
hysterectomy 220 232 8937 8949 O
, 232 233 8949 8950 O
bilateral 234 243 8951 8960 O
tubal 244 249 8961 8966 O
ligation 250 258 8967 8975 O
, 258 259 8975 8976 O
or 260 262 8977 8979 O
bilateral 263 272 8980 8989 O
oophorectomy 273 285 8990 9002 O
) 285 286 9002 9003 O
or 287 289 9004 9006 O
are 290 293 9007 9010 O
not 294 297 9011 9014 O
postmenopausal 298 312 9015 9029 O
; 312 313 9029 9030 O
postmenopause 314 327 9031 9044 O
is 328 330 9045 9047 O
defined 331 338 9048 9055 O
as 339 341 9056 9058 O
amenorrhea 342 352 9059 9069 B-clinical_variable
> 353 354 9070 9071 O
= 354 355 9071 9072 O
12 356 358 9073 9075 B-lower_bound
consecutive 359 370 9076 9087 O
months 371 377 9088 9094 O

all 0 3 9095 9098 O
subjects 4 12 9099 9107 O
of 13 15 9108 9110 O
reproductive 16 28 9111 9123 O
potential 29 38 9124 9133 O
must 39 43 9134 9138 O
agree 44 49 9139 9144 B-contraception_consent
to 50 52 9145 9147 I-contraception_consent
use 53 56 9148 9151 I-contraception_consent
both 57 61 9152 9156 I-contraception_consent
a 62 63 9157 9158 I-contraception_consent
barrier 64 71 9159 9166 I-contraception_consent
method 72 78 9167 9173 I-contraception_consent
and 79 82 9174 9177 I-contraception_consent
a 83 84 9178 9179 I-contraception_consent
second 85 91 9180 9186 I-contraception_consent
method 92 98 9187 9193 I-contraception_consent
of 99 101 9194 9196 I-contraception_consent
birth 102 107 9197 9202 I-contraception_consent
control 108 115 9203 9210 I-contraception_consent
during 116 122 9211 9217 O
the 123 126 9218 9221 O
course 127 133 9222 9228 O
of 134 136 9229 9231 O
the 137 140 9232 9235 O
study 141 146 9236 9241 O
and 147 150 9242 9245 O
for 151 154 9246 9249 O
5 155 156 9250 9251 B-lower_bound
or 157 159 9252 9254 O
7 160 161 9255 9256 B-upper_bound
months 162 168 9257 9263 I-upper_bound
for 169 172 9264 9267 O
women 173 178 9268 9273 B-gender
and 179 182 9274 9277 O
men 183 186 9278 9281 O
respectively 187 199 9282 9294 O
after 200 205 9295 9300 O
the 206 209 9301 9304 O
last 210 214 9305 9309 O
dose 215 219 9310 9314 O
of 220 222 9315 9317 O
study 223 228 9318 9323 B-treatment
drugs 229 234 9324 9329 I-treatment

appearance 0 10 9330 9340 O
of 11 13 9341 9343 O
one 14 17 9344 9347 O
new 18 21 9348 9351 O
bone 22 26 9352 9356 B-chronic_disease
lesion 27 33 9357 9363 I-chronic_disease

